These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36864830)

  • 1. Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging: Alabama Study on Early Age-related Macular Degeneration 2 Baseline.
    McGwin G; Kar D; Berlin A; Clark ME; Swain TA; Crosson JN; Sloan KR; Owsley C; Curcio CA
    Ophthalmol Sci; 2023 Jun; 3(2):100263. PubMed ID: 36864830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Abundance of Macular Xanthophyll Pigment Is Associated with Rod- and Cone-Mediated Vision in Aging and Age-Related Macular Degeneration.
    Kar D; Clark ME; Swain TA; McGwin G; Crosson JN; Owsley C; Sloan KR; Curcio CA
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):46. PubMed ID: 32729911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration: Alabama Study on Early Age-related Macular Degeneration 2 Baseline.
    Owsley C; Swain TA; McGwin G; Clark ME; Kar D; Curcio CA
    Ophthalmol Sci; 2023 Jun; 3(2):100274. PubMed ID: 36875335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique.
    Green-Gomez M; Bernstein PS; Curcio CA; Moran R; Roche W; Nolan JM
    Transl Vis Sci Technol; 2019 Nov; 8(6):41. PubMed ID: 31867142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
    Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
    Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial.
    Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C
    Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Correlation Between Macular Pigment Optical Volume and Retinal Layers Thickness.
    Cozzi M; Casaluci M; Ruggi G; Airaldi M; Romano F; Bertoni A; Green-Gomez M; Nolan JM; Staurenghi G; Invernizzi A
    Invest Ophthalmol Vis Sci; 2024 Jul; 65(8):23. PubMed ID: 39007849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.
    Renzi LM; Hammond BR; Dengler M; Roberts R
    Lipids Health Dis; 2012 Feb; 11():33. PubMed ID: 22375926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing Deposit-Driven Age-Related Macular Degeneration Via Thicknesses of Outer Retinal Bands and Choroid: ALSTAR2 Baseline.
    Emamverdi M; Vatanatham C; Fasih-Ahmad S; Wang Z; Mishra Z; Jain A; Ganegoda A; Clark ME; Habibi A; Ashrafkhorasani M; Owsley C; Curcio CA; Hu ZJ; Sadda SR
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):17. PubMed ID: 38717424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods.
    Curcio CA; McGwin G; Sadda SR; Hu Z; Clark ME; Sloan KR; Swain T; Crosson JN; Owsley C
    BMC Ophthalmol; 2020 May; 20(1):196. PubMed ID: 32429847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
    Dietzel M; Zeimer M; Heimes B; Claes B; Pauleikhoff D; Hense HW
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3452-7. PubMed ID: 21296816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
    Thurnham DI; Nolan JM; Howard AN; Beatty S
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1231-43. PubMed ID: 25311651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
    Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.
    Neuringer M; Sandstrom MM; Johnson EJ; Snodderly DM
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3234-43. PubMed ID: 15326146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.